| Design and assessment of anti-biofilm peptides: steps toward clinical application M Dostert, CR Belanger, REW Hancock Journal of innate immunity 11 (3), 193-204, 2019 | 97 | 2019 |
| Human endogenous retrovirus HERV‐K (HML‐2) activity in prostate cancer is dominated by a few loci W Goering, K Schmitt, M Dostert, H Schaal, R Deenen, J Mayer, ... The Prostate 75 (16), 1958-1971, 2015 | 55 | 2015 |
| Antibiofilm peptides: overcoming biofilm-related treatment failure M Dostert, MJ Trimble, REW Hancock RSC advances 11 (5), 2718-2728, 2021 | 38 | 2021 |
| Model-based analysis of influenza A virus replication in genetically engineered cell lines elucidates the impact of host cell factors on key kinetic parameters of virus growth T Laske, M Bachmann, M Dostert, A Karlas, D Wirth, T Frensing, TF Meyer, ... PLoS computational biology 15 (4), e1006944, 2019 | 17 | 2019 |
| Mathematical modeling as a tool to improve influenza vaccine production processes S Duvigneau, R Dürr, T Laske, M Bachmann, M Dostert, U Reichl, ... IFAC-PapersOnLine 51 (19), 1-4, 2018 | 9 | 2018 |
| The ColR/S two-component system is a conserved determinant of host association across Pseudomonas species CL Wiesmann, Y Zhang, M Alford, CD Hamilton, M Dosanjh, D Thoms, ... The ISME Journal 17 (2), 286-296, 2023 | 8 | 2023 |
| Surviving the host: Microbial metabolic genes required for growth of Pseudomonas aeruginosa in physiologically-relevant conditions CR Belanger, M Dostert, TM Blimkie, AHY Lee, BK Dhillon, BC Wu, ... Frontiers in Microbiology 13, 1055512, 2022 | 8 | 2022 |
| Model-based approach for predicting the impact of genetic modifications on product yield in biopharmaceutical manufacturing—Application to influenza vaccine production S Duvigneau, R Dürr, T Laske, M Bachmann, M Dostert, A Kienle PLoS computational biology 16 (6), e1007810, 2020 | 8 | 2020 |
| Design and assessment of anti-biofilm peptides: steps toward clinical application. J Innate Immun 11: 193–204 M Dostert, CR Belanger, REW Hancock | 5 | 2019 |
| Novel Alligator Cathelicidin As-CATH8 Demonstrates Anti-Infective Activity against Clinically Relevant and Crocodylian Bacterial Pathogens FL Santana, K Estrada, MA Alford, BC Wu, M Dostert, L Pedraz, ... Antibiotics 11 (11), 1603, 2022 | 4 | 2022 |
| Host Defense Peptides: Multifront Attack on Biofilms M Dostert, L Pedraz, REW Hancock Antibiofilm Strategies: Current and Future Applications to Prevent, Control …, 2022 | 1 | 2022 |
| Exploring the biofilm regulatory gene network in Pseudomonas aeruginosa using transposon insertion sequencing M Dostert University of British Columbia, 2023 | | 2023 |
| BosR: A novel biofilm-specific regulator in Pseudomonas aeruginosa M Dostert, CR Belanger, L Pedraz, MA Alford, TM Blimkie, RF Falsafi, ... Frontiers in Microbiology 13, 1021021, 2022 | | 2022 |
| Identifying biofilm regulators as novel targets for antimicrobial drug design M Dostert, CR Belanger, TM Blimkie, R Falsafi, BK Dhillon, AHY Lee, ... biofilms9, 2020 | | 2020 |
| Modeling reveals changes in key parameters of infuenza A virus replication in engineered cell lines T Laske, M Bachmann, M Dostert, T Frensing, A Karlas, D Wirth, U Reichl 11th Annual International Conference on Systems Biology of Human Diseases, 2018 | | 2018 |
| Model-based characterization of influenza A virus production in genetically engineered cell lines elucidates changes in virus replication T Laske, M Bachmann, M Dostert, A Karlas, D Wirth, T Frensing, U Reichl 3rd Workshop on Virus Dynamics, 2017 | | 2017 |
| Untersuchung der Influenzavirus-Vermehrung in A549 Überexpressionsklonen zur Optimierung der Impfstoffproduktion M Dostert Heinrich-Heine-Universität Düsseldorf, 2016 | | 2016 |
| S1 Text. Supporting figures and tables Model-based approach for predicting the impact of genetic modifications on product yield in biopharmaceutical manufacturing-Application … S Duvigneau, R Dürr, T Laske, M Bachmann, M Dostert, A Kienle | | |
